Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erman Akkus

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The New England Journal of Medicine|May 27, 2026
Neoadjuvant GOLP in Intrahepatic CholangiocarcinomaErman Akkus
European Journal of Cancer (Oxford, England : 1990)|March 18, 2025
Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III randomized controlled trialsErman Akkus, Angela Lamarca
American Journal of Physiology. Endocrinology and Metabolism|June 2, 2020
Related molecular mechanisms of COVID-19, hypertension, and diabetesErman Akkus, Mustafa Sahin
Pathology, Research and Practice|February 9, 2021
Fibroblast function in COVID-19Mustafa Sahin, Erman Akkus
Journal of Translational Internal Medicine|October 16, 2020
Comment on "Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management"Mustafa Sahin, Erman Akkus
Journal of Gastroenterology and Hepatology|March 14, 2026
Immune Checkpoint Inhibitor-Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: a Systematic Review and Meta-AnalysisErman Akkus, Hatime Arzu Yaşar
Cancer Treatment Reviews|August 23, 2024
Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectivesErman Akkus, Çağatay Arslan, Yüksel Ürün
Clinical Genitourinary Cancer|February 28, 2025
Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell CarcinomaErman Akkus, Emre Yekedüz, Yüksel Ürün
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2025
Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the ClinicErman Akkus, Timur Tuncalı, Meral Beksac
Critical Reviews in Oncology/Hematology|April 24, 2025
KRAS G12C inhibitors as monotherapy or in combination for metastatic colorectal cancer: A proportion and comparative meta-analysis of efficacy and toxicity from phase I-II-III trialsErman Akkus, Nejat Emre Öksüz, Enes Erul
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The New England Journal of Medicine|May 27, 2026
Neoadjuvant GOLP in Intrahepatic CholangiocarcinomaErman Akkus
European Journal of Cancer (Oxford, England : 1990)|March 18, 2025
Adjuvant chemotherapy compared to observation in resected biliary tract cancers: Survival meta-analysis of phase-III randomized controlled trialsErman Akkus, Angela Lamarca
American Journal of Physiology. Endocrinology and Metabolism|June 2, 2020
Related molecular mechanisms of COVID-19, hypertension, and diabetesErman Akkus, Mustafa Sahin
Pathology, Research and Practice|February 9, 2021
Fibroblast function in COVID-19Mustafa Sahin, Erman Akkus
Journal of Translational Internal Medicine|October 16, 2020
Comment on "Potential Role of ACE2 in Coronavirus Disease 2019 (COVID-19) Prevention and Management"Mustafa Sahin, Erman Akkus
Journal of Gastroenterology and Hepatology|March 14, 2026
Immune Checkpoint Inhibitor-Based Adjuvant Treatment Versus Surveillance in Curatively Treated Hepatocellular Carcinoma: a Systematic Review and Meta-AnalysisErman Akkus, Hatime Arzu Yaşar
Cancer Treatment Reviews|August 23, 2024
Advancements in platinum chemotherapy for metastatic castration-resistant prostate cancer: Insights and perspectivesErman Akkus, Çağatay Arslan, Yüksel Ürün
Clinical Genitourinary Cancer|February 28, 2025
Sodium-Glucose Cotransporter 2 (SGLT2) as a Potential Biomarker and Target in Papillary Renal Cell CarcinomaErman Akkus, Emre Yekedüz, Yüksel Ürün
Clinical Lymphoma, Myeloma & Leukemia|February 13, 2025
Familial Multiple Myeloma: Insights From Epidemiology and Underlying Germline Genetic Predisposition to the ClinicErman Akkus, Timur Tuncalı, Meral Beksac
Critical Reviews in Oncology/Hematology|April 24, 2025
KRAS G12C inhibitors as monotherapy or in combination for metastatic colorectal cancer: A proportion and comparative meta-analysis of efficacy and toxicity from phase I-II-III trialsErman Akkus, Nejat Emre Öksüz, Enes Erul
Pageof 4